Market Opens

“Company”) and Jeff Sujitno, Portfolio Manager, Wellington Square Advisors, and their teams, joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to close the market and celebrate the launch of the Company’s new ETF: Brompton Wellington Square Investment Grade CLO ETF (TSX: BBBB, BBBB.U). Brompton Wellington Square Investment Grade CLO ETF is designed to provide high monthly income and capital preservation through investment in an actively managed portfolio of primarily investment grade-rated collateralized loan obligations (“CLOs”). CLOs will be selected by the Sub-advisor with a minimum of 75% of the portfolio invested in investment grade CLOs. The ETF may also invest up to 25% of its portfolio in CLOs rated BB+ to B-, provided that no more than 5% of the portfolio is invested in CLOs rated below BB-. Brompton Funds is an experienced investment management firm offering income and growth-oriented investment solutions including exchange-traded funds, split share funds, and other TSX-traded investment funds. Brompton leverages over 25 years of experience to provide unique, well-conceived, and value-added strategies to individual investors in Canada with a focus on meeting investors’ needs by offering innovative products with client-friendly terms and supported by strong corporate governance. Wellington Square Advisors is a Canadian based independent investment manager with long-term track record managing funds investing in CLOs, leveraged loans and corporate credit in the U.S., European and Canadian markets. Wellington Square’s partners have backgrounds within CLO management and managing institutional funds for Canada’s largest pension plans.

Dr. David Lim, Breast Surgical Oncologist, Department of Surgery, Women’s College Hospital, Dr. Christine Brezden-Masley, Medical Oncologist, Mount Sinai Hospital and Kimberly Carson, Chief Executive Officer, Breast Cancer Canada, joined Brenda Cunnington, Managing Director, Americas, Trayport at TMX Group, and Board Director for The Lobular Breast Cancer Alliance (“LBCA”) to open the market in recognition of Lobular Breast Cancer Awareness Day. October is Breast Cancer Awareness month, and the 15th was selected as Lobular Breast Cancer Awareness Day to shine a spotlight on the 15% of breast cancer diagnoses each year that are invasive lobular carcinoma (“ILC”). ILC is the second most common type of breast cancer and it behaves differently from the more common ductal breast cancers, often growing in spidery lines and not lumps making it harder to detect with imaging. As a result, the tumours are often missed on mammograms and ultrasounds. Although scientific studies have confirmed that lobular breast cancer is a distinct breast cancer type, less than 1% of breast cancer research funding has been allocated to study ILC and there are no specific treatments. More research is needed to identify better methods for detection and targeted treatments for patients with ILC. The LBCA is the only organization focused on raising awareness of ILC and is the #1 source for information on lobular breast cancer. In consideration of this effort to raise awareness that a “one size fits all” approach for treating breast cancer is no longer adequate, the City of Toronto has issued an official proclamation declaring October 15th, Lobular Breast Cancer Awareness Day.

Chris McHaney, EVP Head of Investment Management and Strategy, Global X Canada (“Global X” or the “Company”) his team, and Laura Somerville, Head of US Index Sales, ICE Indices, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to open the market and celebrate the launch of the Company's four new ETFs: Global X China Hang Seng TECH Index ETF (TSX: CHQQ), Global X 1-3 Year U.S. Treasury Bond Index ETF (TSX: TSTX, TSTX.F, TSTX.U), Global X 20+ Year U.S. Treasury Bond Index ETF (TSX: TLTX, TLTX.F, TLTX.U), Global X Silver Covered Call ETF (TSX: AGCC). Global X Investments Canada Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada. The Global X Fund family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Global X has more than $44 billion of assets under management and 150 ETFs listed on major Canadian stock exchanges. Global X is a wholly-owned subsidiary of the Mirae Asset Financial Group, which manages more than $800 billion of assets across 19 countries and global markets around the world.

Nick Waddell, Founder, Cantech Letter, and other members, joined Dani Lipkin, Managing Director, Global Listings, Toronto Stock Exchange (“TSX”), to open the market to celebrate the 2025 Cantech Letter Conference (“Conference”) in Toronto. The Cantech Investment Conference, in partnership with the TMX Group and Angad Capital, is one the largest gathering for Capital Markets professionals engaged in the technology sector. The Conference is recognized as Canada's foremost technology investment event, and places a strong emphasis on publicly listed companies, providing them with a premier platform to showcase their achievements and future prospects. This dynamic Conference serves as a hub for networking, knowledge exchange, and investment opportunities, featuring cutting-edge product demonstrations and direct engagement with industry leaders. The Conference will also feature engaging panel discussions with industry experts, offering insights into current trends, challenges, and opportunities within the tech sector. For more than fifteen years, Cantech Letter has partnered with dozens of Canadian investment banks to bring investors the latest research on companies in the innovation sectors.